Wells Fargo’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$194K Buy
19,732
+10,995
+126% +$104K ﹤0.01% 5225
2026
Q1
$74.8K Sell
8,737
-17,226
-66% -$155K ﹤0.01% 5264
2025
Q4
$229K Buy
25,963
+5,858
+29% +$67.7K ﹤0.01% 4993
2025
Q3
$266K Buy
20,105
+3,191
+19% +$39.9K ﹤0.01% 4762
2025
Q2
$231K Buy
16,914
+2,410
+17% +$32.4K ﹤0.01% 4690
2025
Q1
$199K Buy
14,504
+5,800
+67% +$84.6K ﹤0.01% 4701
2024
Q4
$149K Buy
8,704
+3,002
+53% +$52K ﹤0.01% 4969
2024
Q3
$105K Buy
+5,702
New +$101K ﹤0.01% 4996

Other funds holding ARDT

Wells Fargo's ARDT Position: Q2 2026 in Review

Wells Fargo increased its Ardent Health (ARDT) stake by 126% in Q2 2026, buying an estimated $104K and bringing the position to 19,732 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #5225.

Wells Fargo first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $266K in Q3 2025. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • Wells Fargo held 19,732 shares of Ardent Health worth $194K as of Q2 2026.
  • Wells Fargo bought 10,995 Ardent Health shares in Q2 2026, an estimated $104K.
  • Ardent Health made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5225 holding.
  • Wells Fargo first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
  • Wells Fargo's Ardent Health position peaked at $266K in Q3 2025.
  • 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.